Viemed Healthcare (VMD) Stock Price, News & Analysis

Company Overview

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Key Stats

• Today's Range: $6.89 to $7.08
• 50-Day Range: $6.32 to $7.40
• 52-Week Range: $6.14 to $9.81
• Volume: 644,738 shs
• Average Volume: 142,367 shs
• Market Capitalization: $273.48 million
• P/E Ratio: 23.07
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Viemed Healthcare Stock Analysis - MarketRank™

Viemed Healthcare scored higher than 34% of companies evaluated by MarketBeat, and ranked 790th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Viemed Healthcare.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Viemed Healthcare is 23.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of Viemed Healthcare is 23.07, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.21.

Price to Book Value per Share Ratio

Viemed Healthcare has a P/B Ratio of 2.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.14% of the float of Viemed Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Viemed Healthcare has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viemed Healthcare has recently increased by 20.12%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Viemed Healthcare does not currently pay a dividend.

Dividend Growth

Viemed Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.14% of the float of Viemed Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Viemed Healthcare has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viemed Healthcare has recently increased by 20.12%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.93

News Sentiment

Viemed Healthcare has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Viemed Healthcare this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for VMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Viemed Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VMD Stock Analysis - Frequently Asked Questions

How have VMD shares performed this year?

Viemed Healthcare's stock was trading at $8.02 at the start of the year. Since then, VMD shares have decreased by 13.7% and is now trading at $6.92.
View the best growth stocks for 2025 here.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its earnings results on Wednesday, May, 7th. The company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06. The business had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a trailing twelve-month return on equity of 9.49% and a net margin of 5.28%.
Read the conference call transcript.

Who are Viemed Healthcare's major shareholders?

Viemed Healthcare's top institutional shareholders include Nantahala Capital Management LLC (2.36%), Goldman Sachs Group Inc. (1.91%), Goldman Sachs Group Inc. (1.91%) and Punch & Associates Investment Management Inc. (1.47%). Insiders that own company stock include Nitin Kaushal, Randy E Dobbs, Timothy Smokoff and Sabrina Heltz.
View institutional ownership trends.

How do I buy shares of Viemed Healthcare?

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Viemed Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Cassava Sciences (SAVA), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 6/29/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:VMD
• CIK: 1729149
• Web: www.viemed.com
• Phone: (337) 504-3802
• Fax: N/A
• Employees: 1,179
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.30
• Trailing P/E Ratio: 23.07
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $11.27 million
• Net Margins: 5.28%
• Pretax Margin: 7.61%
• Return on Equity: 9.49%
• Return on Assets: 7.14%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.38
• Quick Ratio: 1.26

Sales & Book Value

• Annual Sales: $224.26 million
• Price / Sales: 1.22
• Cash Flow: $0.94 per share
• Price / Cash Flow: 7.35
• Book Value: $3.41 per share
• Price / Book: 2.03

Miscellaneous

• Outstanding Shares: 39,520,000
• Free Float: 31,619,000
• Market Cap: $273.48 million
• Optionable: Not Optionable
• Beta: 1.38